131 related articles for article (PubMed ID: 22023028)
1. Genomics and drug discovery.
Lundstrom K
Future Med Chem; 2011 Nov; 3(15):1855-8. PubMed ID: 22023028
[No Abstract] [Full Text] [Related]
2. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
3. [Advance in the research and discovery of novel drugs based on chemogenomics].
He BK; Ma ZC; Wang YG; Gao Y
Yao Xue Xue Bao; 2008 Nov; 43(11):1077-81. PubMed ID: 19239023
[TBL] [Abstract][Full Text] [Related]
4. Genomics and personalized medicine.
Sadee W
Int J Pharm; 2011 Aug; 415(1-2):2-4. PubMed ID: 21539903
[TBL] [Abstract][Full Text] [Related]
5. Dealing with the evidence dilemma in genomics and personalized medicine.
Khoury MJ
Clin Pharmacol Ther; 2010 Jun; 87(6):635-8. PubMed ID: 20485318
[TBL] [Abstract][Full Text] [Related]
6. The application of next-generation sequencing technologies to drug discovery and development.
Woollard PM; Mehta NA; Vamathevan JJ; Van Horn S; Bonde BK; Dow DJ
Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
[TBL] [Abstract][Full Text] [Related]
7. The role of bioinformatics in diabetes drug development--and precision medicine.
Dangi-Garimella S
Am J Manag Care; 2014 May; 20(8 Spec No.):E1. PubMed ID: 25617937
[No Abstract] [Full Text] [Related]
8. Integrating genomics across drug discovery and development.
Debouck C
Toxicol Lett; 2009 Apr; 186(1):9-12. PubMed ID: 18930125
[TBL] [Abstract][Full Text] [Related]
9. Counterpoint: Data first.
Golub T
Nature; 2010 Apr; 464(7289):679. PubMed ID: 20360719
[No Abstract] [Full Text] [Related]
10. From genomic landscapes to personalized cancer management-is there a roadmap?
Swanton C; Caldas C
Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.
Momper JD; Wagner JA
Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660
[TBL] [Abstract][Full Text] [Related]
12. Unlocking the potential of the human genome with RNA interference.
Hannon GJ; Rossi JJ
Nature; 2004 Sep; 431(7006):371-8. PubMed ID: 15372045
[TBL] [Abstract][Full Text] [Related]
13. Genomics in medicine: From promise to practice.
Urban MF
S Afr Med J; 2015 Sep; 105(7):545-7. PubMed ID: 26428748
[No Abstract] [Full Text] [Related]
14. Beyond genomics: interpreting the 93% of the human genome that does not encode proteins.
Fabbri M; Calin GA
Curr Opin Drug Discov Devel; 2010 May; 13(3):350-8. PubMed ID: 20443168
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenomics genomics approaches to optimizing drug therapy].
Shi J; Chen S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
[TBL] [Abstract][Full Text] [Related]
16. [Rheumatoid arthritis: problems and significance of personalized medicine].
Ter Arkh; 2012; 84(5):5-9. PubMed ID: 22830204
[TBL] [Abstract][Full Text] [Related]
17. Introduction to the theme "Precision medicine and prediction in pharmacology".
Insel PA; Amara SG; Blaschke TF
Annu Rev Pharmacol Toxicol; 2015; 55():11-4. PubMed ID: 25562643
[No Abstract] [Full Text] [Related]
18. Can medical genetics and evolutionary biology inspire drug target identification?
Wang ZY; Fu LY; Zhang HY
Trends Mol Med; 2012 Feb; 18(2):69-71. PubMed ID: 22172275
[TBL] [Abstract][Full Text] [Related]
19. Conference scene: pharmacogenomics: from cell to clinic (part 2).
Siest G; Medeiros R; Melichar B; Stathopoulou M; Van Schaik RH; Cacabelos R; Abt PM; Monteiro C; Gurwitz D; Queiroz J; Mota-Filipe H; Ndiaye NC; Visvikis-Siest S
Pharmacogenomics; 2014 Apr; 15(6):739-44. PubMed ID: 24897282
[TBL] [Abstract][Full Text] [Related]
20. Structural genomics approach to drug discovery for Mycobacterium tuberculosis.
Ioerger TR; Sacchettini JC
Curr Opin Microbiol; 2009 Jun; 12(3):318-25. PubMed ID: 19481971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
